A Resilient Drug Supply Chain Needs More Than DSCSA Compliance
There are more current and broader supply chain risks that parallel the challenges the FDA is seeking to address with the DSCSA.
Stay updated with breaking news from Operational Technology Assets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There are more current and broader supply chain risks that parallel the challenges the FDA is seeking to address with the DSCSA.
Share this article Share this article ResearchAndMarkets.com's offering. This research service analyzes the global critical infrastructure cyber security market, identifying particular trends, best practices, and customer decision-making factors within four critical national infrastructure segments: oil and gas, utilities, maritime ports, and airports. A full market analysis is included with market sizing and forecasts from 2019 to 2030, using a base year of 2019, and segmented by customer vertical and region. Analysis on how the global COVID-19 pandemic will affect short-term spending in the...